红会HONGHUI品牌怎么样 申请店铺

更新时间:2024-10-28
红会HONGHUI是哪个国家的品牌?「红会HONGHUI」是 桂林红会药业有限公司 旗下著名品牌。该品牌发源于桂林市,由创始人徐 * 国在1992年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
红会HONGHUI怎么样

桂林红会药业有限公司,原名桂林红会制药厂,始创于1992年,是一家大型现代化制药企业。公司于2009年完成改制,并与贵州大学合作成立银杏叶研究院,专业从事银杏叶提取、药品研发,并拥有多项专利技术。

公司位于自古被誉为“楚越往来之要冲”的广西桂林市灵川县,依托当地独特的银杏资源,建立了专业化的集银杏种植、产品转化、生产销售为一体的银杏生态产业园。

公司专注于中、西药成方制剂的研究、生产、销售及开发研制中药新药。目前公司拥有片剂、胶囊剂、颗粒剂、口服液4条生产线,配备有现代化的生产设备和检测仪器,建立了完整的产品质量监控体系。主打产品有心脑血管系列、妇科系列、清热解毒系列、感冒止咳系列、胃肠止痛等6大系近30多种中成药。

公司创立以来,坚持以“专注专业,仁心良药”的企业文化理念,坚持以“专注”的行事准则对制药过程进行严谨的流程控制,建立了完整的产品质量监控体系,严格按GMP进行药品生产与控制,产品具有优良稳定的品质;坚持以“专业”来衡量并不断引进优质的制药技术,不断加大研发投入,配备有高效液相色谱仪、红外分光光度计、原子吸收分光光度计、气相色谱仪等仪器,对原药材、药品进行检测。

红会药业一贯秉承“博爱、奉献”的红会精神,始终具有良心企业强烈的社会责任使命感,在企业壮大的同时,不断地回馈社会。

今天的“红会”更加务实求真,奋力拼搏,红会人正为了“振兴国药,造福人类”贡献自己的智慧和力量。


Guilin Honghui Pharmaceutical Co., Ltd., formerly known as Guilin Honghui pharmaceutical factory, was founded in 1992. It is a large modern pharmaceutical enterprise. The company completed restructuring in 2009, and established ginkgo leaf Research Institute in cooperation with Guizhou University, specializing in Ginkgo leaf extraction, drug research and development, and has a number of patent technologies. The company is located in Lingchuan County, Guilin City, Guangxi Province, which has been known as the "hub of Chu Yue communication" since ancient times. Relying on the unique ginkgo resources, the company has established a professional ginkgo ecological industrial park integrating ginkgo planting, product transformation, production and sales. The company focuses on the research, production, sales and development of new Chinese medicine. At present, the company has 4 production lines of tablet, capsule, granule and oral liquid, equipped with modern production equipment and testing instruments, and established a complete product quality monitoring system. The main products include 6 series of nearly 30 kinds of Chinese patent medicines, such as cardio cerebrovascular series, gynecology series, heat clearing and detoxification series, cold and cough relieving series, gastrointestinal pain relieving series. Since its establishment, the company adheres to the corporate culture concept of "focusing on specialty, caring and good medicine", adheres to the strict process control of the pharmaceutical process based on the principle of "focusing on", establishes a complete product quality monitoring system, strictly carries out drug production and control in accordance with GMP, and the products have excellent and stable quality; Adhere to "professional" to measure and constantly introduce high-quality pharmaceutical technology, constantly increase R & D investment, equipped with high-performance liquid chromatograph, infrared spectrophotometer, atomic absorption spectrophotometer, gas chromatograph and other instruments to test the original medicine and drugs. Honghui pharmaceutical industry has always adhered to the spirit of "fraternity and dedication" and always has a strong sense of social responsibility and mission of conscientious enterprises, and constantly gives back to the society while the enterprises grow. Today's "Red Cross Society" is more pragmatic, realistic and hard-working. People of Red Cross Society are contributing their wisdom and strength to "vitalize national medicine and benefit mankind".

本文链接: https://brand.waitui.com/85c24ea98.html 联系电话:0773-6828808,0551-62892501

千城特选小程序码

7×24h 快讯

香港特区政府发表有关在金融市场负责任地应用人工智能的政策宣言

香港特区政府今日(28日)发表有关在金融市场负责任地应用人工智能的政策宣言。特区政府财政司司长陈茂波表示,作为国际金融中心,香港对在金融市场应用人工智能抱开放和审慎的态度。政策宣言清晰阐明特区政府的政策立场及方针,推动金融市场负责任地应用人工智能。随着人工智能技术不断发展,特区政府会密切关注市场发展,以及参考海内外经验,充分利用香港汇聚内地和国际数据、资讯自由流通的独有优势,推动金融服务业应用人工智能,因地制宜加速培育新质生产力。(大湾区之声)

31分钟前

香港预计明年年中试行与内地跨境支付

香港金融管理局总裁余伟文今日(28日)表示,预计将于明年年中试行内地跨境支付和“转数快”。(大湾区之声)

31分钟前

半日主力资金加仓计算机股,抛售银行、电子股

主力资金早间净流入计算机、机械设备、国防军工等板块,净流出银行、电子、电力设备等板块。具体到个股来看,银之杰、上海电气、四川长虹获净流入28.69亿元、20.66亿元、17.23亿元。净流出方面,常山北明、润和软件、隆基绿能遭抛售8.6亿元、6.18亿元、5.77亿元。(第一财经)

31分钟前

印尼禁售iPhone 16,称苹果未履行投资承诺

10月28日消息,印尼政府日前宣布禁止在该国销售iPhone 16,称苹果公司未履行在印尼国内的投资承诺。印尼工业部早些时候表示,苹果承诺向印尼基础设施和本地采购投资1.7万亿印尼盾(约合1.09亿美元),但实际兑现金额仅为1.48万亿印尼盾。(界面)

31分钟前

小米SU7本月目标交付2万台,雷军:还在冲刺

36氪获悉,10月27日晚,小米董事长兼CEO雷军在微博发文回应网友问题。对于小米15系列涨价幅度,雷军称即便涨价,小米15依旧物超所值,“相比往代同内存版本的涨价幅度,也肯定让大家觉得‘贵得有理由’”。此外,对于小米SU7单月交付2万台目标能否完成,雷军表示:“还在努力冲刺”。

31分钟前

本页详细列出关于红会HONGHUI的品牌信息,含品牌所属公司介绍,红会HONGHUI所处行业的品牌地位及优势。
咨询